Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Journal Article

Harrison, Claire, Andreasson, Bjorn, Cambier, Nathalie, Gerds, Aaron, Grosicki, Sebastian, Illes, Arpad, Kiladjian, Jean-Jacques, Lavie, David, Mesa, Ruben, Palmer, Jeanne, Passamonti, Francesco, Perkins, Andrew, Sacha, Tomasz, Scheid, Christof, Todorieva-Todorova, Doroteya, Vannucchi, Alessandro, Wozny, Tomasz, Klencke, Barbara, Kowalski, Mark and Verstovsek, Srdan (2020). Long-Term Safety of Momelotinib in JAK Inhibitor-Naive and Previously JAK Inhibitor-Treated Intermediate-/High-Risk Myelofibrosis Patients. Clin. Lymphoma Myeloma Leuk., 20. S. S330 - 2. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669

Harrison, Claire N., Egyed, Miklos, Szoke, Anita, Suvorov, Aleksandr, Perkins, Andrew ORCID: 0000-0003-3644-7093, Mayer, Jiri, Ganly, Peter, Schouten, Harry C., Tosi, Patrizia, Farber, Charles Michael, Zachee, Pierre, Scheid, Christof, Dean, James P., Zhou, Huafeng, Kiladjian, Jean-Jacques, Vannucchi, Alessandro M., Nangalia, Jyoti, Mead, Adam and Mesa, Ruben A. (2016). Outcomes in patients with myelofibrosis and RBC-transfusion dependence in the phase III PERSIST-1 study of pacritinib vs. best available therapy. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kvasnicka, Hans Michael, Orazi, Attilio, Thiele, Juergen, Barosi, Giovanni, Bueso-Ramos, Carlos E., Vannucchi, Alessandro M., Hasserjian, Robert P., Kiladjian, Jean-Jacques ORCID: 0000-0002-8121-438X, Gianelli, Umberto, Silver, Richard, Mughal, Tariq I. and Barbui, Tiziano (2017). European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia. Am. J. Hematol., 92 (10). S. 1062 - 1068. HOBOKEN: WILEY. ISSN 1096-8652

Mesa, Ruben A., Egyed, Miklos, Szoke, Anita, Suvorov, Aleksandr, Perkins, Andrew ORCID: 0000-0003-3644-7093, Mayer, Jiri, Ganly, Peter, Jourdan, Eric, Schouten, Harry C., Tosi, Patrizia, Farber, Charles Michael, Zachee, Pierre, Scheid, Christof, Dean, James P., Cernohous, Paul, Nangalia, Jyoti, Kiladjian, Jean-Jacques, Vannucchi, Alessandro M., Mead, Adam and Harrison, Claire N. (2015). Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), or post-essential thrombocythemia-myelofibrosis (PET-MF). J. Clin. Oncol., 33 (18). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Mesa, Ruben A., Egyed, Miklos, Szoke, Anita, Suvorov, Aleksandr, Perkins, Andrew ORCID: 0000-0003-3644-7093, Mayer, Jiri, Ganly, Peter, Schouten, Harry C., Tosi, Patrizia, Farber, Charles Michael, Zachee, Pierre, Scheid, Christof, Dean, James P., Granston, Tanya, Kiladjian, Jean-Jacques, Vannucchi, Alessandro M., Nangalia, Jyoti, Mead, Adam and Harrison, Claire N. (2016). Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): 60 week follow-up of the phase III PERSIST-1 trial. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Wed Oct 20 02:58:47 2021 CEST.